1-4 of 4
human antichimeric antibody
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors of Early Response to Single Agent Rituximab in Patients with Indolent Lymphoma.

Divi Cornec, Adrian Tempescul, Solène Querellou, Amani Mankai, Pascal Hutin, Florence Cymbalista, Christian Berthou, Yves Renaudineau, Pierre Youinou
Journal: Blood
Blood (2009) 114 (22): 1946.
https://doi.org/10.1182/blood.V114.22.1946.1946
Published: 2009
Journal Articles

Evaluation of Humoral Immune Responses to Vaccination with Tetanus Toxoid and KLH in Rituximab-Treated Follicular Non-Hodgkin’s Lymphoma Patients Compared to Healthy Volunteers

M. Wayne Saville, MD, FACP, FRCPA, Nancy Valente, MD, Rachelle Perea, Kye Gilder, Judith Berlfein, Ilya Zyuzgin, PhD, David Belada, MD., PhD., Andre Banat, MD, MBA, Tudor Ciuleanu, MD
Journal: Blood
Blood (2008) 112 (11): 3066.
https://doi.org/10.1182/blood.V112.11.3066.3066
Published: 2008
Journal Articles

A Phase I Study of 90 Y-Ibritumomab-Tiuxetan ( 90 Y-It) in Children with Recurrent/Refractory CD20 Positive Lymphoma: A Cog Phase I Consortium Study.

Mitchell S. Cairo, MD, Erin Cooney, CPNP, Mark Krailo, PhD, Richard Belanger, MS, CHP, Sherrie L. Perkins, MD, PhD, Rashid Fawwaz, MD, Anne Angiolillo, MD, Peter Adamson, MD
Journal: Blood
Blood (2005) 106 (11): 2448.
https://doi.org/10.1182/blood.V106.11.2448.2448
Published: 2005
Journal Articles

Re-Treatment with Rituximab in ITP: Comparison of Standard Dose with 2 Forms of Augmented Rituximab.

Aisha N. Hasan, MD, James B. Bussel, MD
Journal: Blood
Blood (2005) 106 (11): 1237.
https://doi.org/10.1182/blood.V106.11.1237.1237
Published: 2005